The U.S. Food and Drug Administration (FDA) on July 5 paused its marketing denial order on Juul electronic cigarettes while it carries out a review into “scientific issues” unique to the company’s application.
“On July 5, 2022, FDA administratively stayed the marketing denial order. This administrative stay temporarily suspends the marketing denial order during the additional review but does not rescind it,” the department announced on Twitter.